Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN) [EARLY_Phase 1]

View source ↗

Summary

This document reports an Early Phase 1 clinical trial studying sympathetic transduction in obesity-associated hypertension. The study is currently RECRUITING at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hypertension, Obesity | EARLY_Phase 1 | Status: RECRUITING